In conclusion, we found that there was a need to summarize a large sample size of tumors to determine the association between tumor-infiltrating FoxP3+Treg cells and prognosis in pancreatic cancer in order to gain insight into whether FoxP3+Treg cells can provide useful guidance for the biological treatment of pancreatic cancer. This evidence concerns the gene FOXP3 and familial pancreatic carcinoma.